Cutting edge discussions on protein & antibody engineering and development strategies, advancing bispecifics to the clinic & therapeutic use, bioanalysis and vaccine development
The Proteins & Antibodies Congress includes...
Over 300 attendees representing global pharmaceutical organisations, leading biotech and internationally renowned academic institutions.
Over 30 case studies, presentations, panel debates & roundtable discussions focused on the key issues in protein & antibody engineering, characterisation & developability updates and vaccine development.
Agenda at a Glance